Mobile Menu Button
  • 27 Feb 17

A Genetic Variant Can Predispose South Asians to Hypertrophic Cardiomyopathy

A genetic variant of myosin binding protein C, cardiac (MYBPC3), can predispose South Asians to hypertrophic cardiomyopathy (HCM), but early screening could lower its incidence. Sakthivel Sadayappan, PhD, MBA, professor, division of cardiovascular health and disease and director of the heart branch of Heart, Lung and Vascular Institute, University of Cincinnati Medical Center (UC Medical

Learn More →
  • 04 Jan 18

UC Medical Center Researchers Advancing Precision Medicine

Researchers at the University of Cincinnati (UC) Medical Center are advancing the treatment of hypertrophic cardiomyopathy (HCM) and heart failure through the study and application of precision medicine (PM). “From the perspective of PM, a key goal involves uncovering the direct clinical relationship between genetic variants and disease phenotypes to allow for customized healthcare delivery

Learn More →